ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat immunoglobulin A nephropathy, address chronic kidney disease in specific ...

ENYO Pharma ("ENYO"), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

New global research shows that chronic kidney disease is climbing the ranks of leading causes of death, while millions of ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Pediatric kidney disease requires early diagnosis and specialized care to support growth, development, and long-term health.

Researchers at the Perelman School of Medicine identified over 1,000 genes that could serve as potential treatment targets for kidney disease in a newly published study. The study marks the most ...

Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease. Although late-stage kidney cancer generated ...

Employment rates for patients with end-stage kidney disease were higher for those with access to home hemodialysis or evening ...

West Nile virus is the leading mosquito-borne infection in the United States. Neuroinvasive disease affects less than 1% but it can be fatal.